Management of pregnancy after fertility-sparing surgery for cervical cancer

Acta Obstet Gynecol Scand. 2020 Jul;99(7):830-838. doi: 10.1111/aogs.13917. Epub 2020 Jun 1.

Abstract

Cervical cancer is increasingly diagnosed in women who have not yet completed their reproductive plans. For women with early-stage disease (FIGO stage IA1-IB1), fertility-sparing procedures, such as conization, trachelectomy or radical trachelectomy, represent the treatments of choice. However, women who undergo repeated conization or trachelectomy represent a challenge for obstetricians because they are at increased risk of infertility, mid-trimester miscarriage, preterm premature rupture of membranes and preterm delivery. So far, the evidence-based guidance on the management of these pregnancies is limited. This article reviews the literature discussing pregnancy management in women after fertility-sparing surgery for early cervical cancer. Although the evidence is limited, certain measures are desirable, including screening and treatment of asymptomatic bacteriuria, screening for cervical incompetence and progressive cervical shortening by transvaginal ultrasonography, and fetal fibronectin testing. Vaginal progesterone supplementation should be primary prevention for all women after trachelectomy. Women with a history of preterm delivery or late miscarriage may benefit from cervical cerclage. Elective delivery by cesarean section in the early-term period is desirable.

Keywords: cerclage; fertility-sparing surgery; fetal fibronectin; preterm labor; preterm premature rupture of membranes; trachelectomy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adult
  • Female
  • Fertility Preservation / methods*
  • Gynecologic Surgical Procedures / methods
  • Humans
  • Pregnancy
  • Pregnancy Outcome*
  • Pregnancy Rate
  • Uterine Cervical Neoplasms / surgery*